📰 Current Report News
Page 121 - Current Report News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Report. Real-time updates on events, politics, business and more.
August 11, 2023
Significant event to be reported:Reporting of transactions with related parties according to art. 108paragraph 3 and paragraph 13 of Law no. 24/2017 - Republished ... -August 11, 2023 at 04:06 am- MarketScreener
August 11, 2023
11.08.2023 - End-of-Phase 2 Meeting with FDA Scheduled for Q4 2023 for Oral APX3330 in Diabetic Retinopathy (DR) Cash Balance of $40 Million Expected to Fund Operations into 2025 Nyxol RM PDUFA date September 28, 2023; Approval would trigger $10 ...
August 11, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
August 11, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...
August 11, 2023
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
August 11, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
August 11, 2023
Gmgi_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
August 11, 2023
Kaleyra announces changes in the management team: Nicola Junior Vitto departure and new appointment of Mauro CarobeneNEW YORK, Aug. 11, 2023 /PRNe...
August 10, 2023
Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells that harden those cells against HIV infection and depletion, thus allowing those cells...
August 10, 2023
Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV...